Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q2

3034.TEDINET S100PL5A
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥82.5bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥166.2bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥81.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥4.0bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥4.2bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥4.2bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥10.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.3bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥4.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥4.3bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥2.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥2.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥91.0bnat 2022-09-30Cons.Assets
Total assets¥96.0bnat 2022-03-31Cons.Assets
Total assets¥97.6bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥45.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥52.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥45.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥43.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥41.1bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥14.5bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥16.7bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥14.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥16.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥16.2bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥19.5bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥4.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥10.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥3.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥10.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥64.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.922022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥149.512021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥66.982021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.762021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio50.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio42.1%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥181m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥181m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.7bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-09-30¥75.6bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-09-30¥75.6bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥58m
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.1bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥7.0bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥6.9bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥123m
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥645m
—segment totalrevenue2022-04-01 → 2022-09-30¥82.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥82.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥181m
—segment totalsegment profit2022-04-01 → 2022-09-30¥5.7bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥193m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥193m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥1.7bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2021-04-01 → 2021-09-30¥75.4bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2021-04-01 → 2021-09-30¥75.3bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥40m
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2021-04-01 → 2021-09-30¥5.2bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥6.6bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥6.5bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥153m
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥663m
—segment totalrevenue2021-04-01 → 2021-09-30¥82.0bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥81.8bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥193m
—segment totalsegment profit2021-04-01 → 2021-09-30¥5.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 524
ItemContextValueUnit
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E03476-000MedicalRelatedReportableSegmentMember123000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember181000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-181000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E03476-000HealthInsurancePharmacyReportableSegmentsMember75615000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E03476-000MedicalRelatedReportableSegmentMember7025000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember82641000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-181000000JPY
Net salesCurrentYTDDuration82459000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E03476-000HealthInsurancePharmacyReportableSegmentsMember5056000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E03476-000MedicalRelatedReportableSegmentMember645000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember5702000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-1680000000JPY
Operating incomeCurrentYTDDuration4022000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第31期第２四半期 (自 2022年７月１日 至 2022年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)クオールホールディングス株式会社
Company name in english cover pageFilingDateInstantQol Holdings Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　中村　敬
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階
Telephone number address of registered headquarter cover pageFilingDateInstant03－6430－9060
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経営管理部　部長　緒方　伸一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階
Telephone number nearest place of contact cover pageFilingDateInstant03－6430－9060
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経営管理部　部長　緒方　伸一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE03476
Fund codeFilingDateInstant－
Security codeFilingDateInstant30340
Filer name in japaneseFilingDateInstant
Original text (Japanese)クオールホールディングス株式会社
Filer name in englishFilingDateInstantQol Holdings Co., Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2022-04-01
Current period end dateFilingDateInstant2022-09-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2023-03-31
Previous fiscal year start dateFilingDateInstant2021-04-01
Comparative period end dateFilingDateInstant2021-09-30
Previous fiscal year end dateFilingDateInstant2022-03-31
Next fiscal year start dateFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass